SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-09-000255
Filing Date
2009-02-13
Accepted
2009-02-13 11:48:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G HOLDINGS REPORT AMENDMENT nps0209a4.txt SC 13G/A 11617
  Complete submission text file 0001172661-09-000255.txt   13479
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44877 | Film No.: 09599849
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 767 3RD AVENUE 30TH FLOOR NEW YORK NY 10017
Business Address 767 3RD AVENUE 30TH FLOOR NEW YORK NY 10017 2126845700
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G/A